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Abstract: Atrial fibrillation is a major health problem in Western countries, and is associated 
with considerable morbidity and resource consumption. Safe and reliable surgical techniques 
for the termination of this arrhythmia have been developed since the time of the original Cox 
“maze I” procedure. Novel equipment based on radiofrequency and microwave technologies 
can be employed to create transmural atrial lesions, even in the context of minimally invasive 
surgery to the atrioventricular valves via right minithoracotomy. The aim of this paper is to 
review the recent literature on this approach, and the clinical results in terms of arrhythmia 
termination and postoperative morbidity. With the aim to substantiate the practice of a simple, 
yet reliable, surgical ablation during minimally invasive heart valve surgery, we discuss the 
results of different patterns of atrial lesions having different degrees of surgical complexity. 
Finally, minimally invasive epicardial ablation for lone atrial fibrillation represents an emerging 
surgical  indication. The  results  of  state-of-the-art  transcatheter  ablation  represent  now  its 
benchmark of comparison.
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Introduction
Atrial fibrillation (AF) is the most common cardiac rhythm disturbance in adults, 
and is potentially associated with important cardiovascular morbidity and mortality, 
mainly due to thromboembolism.1 The association with mitral valvular disease is well 
known. The rate of failure of medical rhythm control therapy may be as high as 85% 
at two years.2
Despite adequate correction of valvular disease, AF is expected to persist post-
operatively in those patients undergoing an operation on the mitral valve, and with 
persistent AF or paroxysmal AF lasting more than one year.3 This observation, coupled 
with the encouraging results of the Cox maze procedure as a treatment to restore 
sinus rhythm in patients with structural heart disease,4,5 has justified the practice of 
performing arrhythmia surgery in these individuals. This practice has been recently 
supported by a controlled randomized trial6 which highlighted the superiority of the 
radiofrequency maze ablation procedure in restoring sinus rhythm versus postopera-
tive rhythm control treatment.
In the current era, minimally invasive strategies are becoming the standard of care 
for surgery to the atrioventricular valves. While these procedures are proven to be repro-
ducible and their number is increasing, the research has focused on the   development of 
equipment designed for surgical AF ablation via minimally invasive access. The aim Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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of this paper is to review the current literature systematically 
regarding the feasibility, reliability, and   surgical results of 
minimally invasive surgical techniques for the treatment of 
AF versus those obtained via the conventional surgical route, 
with particular attention to the results of different ablation 
line patterns.
Methods
A literature search was conducted for the period December 
2009–January 2010 using the Medline-National Library of 
Medicine online database. The search was limited to English 
language prospective or retrospective studies of surgical 
epicardial AF ablation via an access different to that of con-
ventional median sternotomy, with or without concomitant 
surgery to the atrioventricular valve(s). The terms “atrial 
fibrillation”, “ablation”, “surgical treatment”, “minimally 
invasive”, and “thoracotomy” were entered in the search 
heading. Further inclusion criteria were presentation of both 
early postoperative results and a clinical follow-up lasting 
at least 12 months for arrhythmia recurrence, reporting of 
data on late complications (including stroke, heart block, and 
pacemaker implantation) and on mortality. Study quality was 
evaluated in a blinded fashion by two investigators. Dupli-
cate studies published on the same patient population were 
excluded. Divergent judgments were resolved by consensus 
of the investigators. For the purposes of the study, full median 
sternotomy was defined as the “conventional surgical route” 
for AF ablation, irrespective of the technique, energy source, 
and lesion pattern adopted to perform the ablation, with or 
without concomitant surgery for structural heart disease. The 
“minimally invasive approach” was defined as any approach 
entailing surgical incision other than median sternotomy (ie, 
thoracotomy, minithoracotomy, either with direct vision or 
thoracoscopy), with or without surgery for structural heart 
disease (Figures 1 and 2). Finally, in the present paper, no 
differentiation in data extraction has been made between the 
slightly different types of minimally invasive technique used 
to approach the heart (ie, fully thoracoscopic versus non-fully 
thoracoscopic systems).
Subsequently, sample size calculation for a prospective 
study comparing the follow-up results of transcatheter versus 
epicardial ablation of lone AF was performed. As a point of 
AB
Figure 1 Schematic drawing of surgical incisions. A) Full median sternotomy entails complete division of the sternal bone in the midline in order to expose the heart and the 
great vessels. B) The minimally invasive approaches for surgery to the atrioventricular valve(s) and AF ablation entail a right minithoracotomy, most frequently in the fourth 
intercostal space, the length of which ranges from 3 cm to 8–9 cm, depending on the technique. 
Abbreviation: AF, atrial fibrillation.Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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Figure 2 Setup of the port access system. Cardiopulmonary bypass is established by cannulation of the common femoral vessels (both for venous drainage from the inferior 
vena cava and arterial inflow in the common femoral artery). A second venous drainage cannula is placed in the superior vena cava through the right internal jugular vein. 
A right minithoracotomy in the inframammary groove is used to lead prosthetic material into the chest. A camera port is used to provide full videoscopic assistance during 
the procedure, and three additional instrument ports are used. An expandable balloon inserted through the femoral artery is used to clamp the ascending aorta from the 
inside (aortic endoclamp), and to deliver cardioplegia to protect the myocardium during the arrest period.
reference, we used follow-up results of patients subjected 
to transcatheter ablation and to combined cardiac surgery 
and AF ablation in our institution. The endpoints used in 
our analysis were rate of recurrent AF at hospital discharge 
and rate of recurrent AF at the six-month follow-up. A 0.9 
statistical power was applied, and the analysis was conducted 
using the PS Power and Sample Size calculation software 
ver. 3.0 for Windows.
Epicardial ablation via full median 
sternotomy
A pooled meta-analysis investigation published in 2005 has 
confirmed the usefulness of AF ablation during mitral surgery 
to maintain sinus rhythm and to reduce the risk of stroke 
  during follow-up versus mitral surgery alone. The association 
between the maze procedure and increased risk of postopera-
tive pacemaker requirement, as mentioned in several previous 
studies, was also confirmed. However, a proportion of these 
cases may theoretically represent unmasked pre-existing 
sinus node dysfunction; thus, pacemaker implantation may 
not be attributable to the surgical procedure itself in all indi-
viduals. Discrimination among these two patient categories 
needs to be researched further. In the same meta-analysis, 
an increased rate of postoperative revision for bleeding was 
associated with AF ablation. As such, bleeding in these 
patients is almost entirely attributable to the atrial incisions of 
the “cut-and-sew” technique. In fact, the incidence of revision 
for bleeding in the literature included in this   meta-analysis is Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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consistently lower whenever RF or cryoablation techniques 
were used.7–15
Despite continuing methodologic improvements, the 
success rates with transcatheter endocardial ablation for 
AF may be less than optimal, despite employment of state-
of-the-art technologies. It emerged from randomized trials 
that the coupling of pulmonary vein isolation with left atrial 
linear lesions through the mitral annulus and the left atrial 
appendage may improve the results.16 However, reported 
success rates approach 57% at one year and 53% at three 
years. A second ablation procedure or more complex and 
staged ablation patterns may improve the outcome.17 Such 
complex transcatheter ablation strategies may not be cost-
effective in a time of escalating medical costs.18 Conversely, 
epicardial left atrial ablation using current radiofrequency 
technology has a success rate of 85% at two years after one 
single procedure.19 Other papers have reported a 94% rhythm 
control rate at follow-up if additional lesions are produced 
within the right atrium.8 Nonetheless, a median sternotomy 
incision has been the price of performing a maze procedure 
for a long time, with its ensuing morbidity, hospitalization, 
and prolonged postprocedural recovery. These factors have 
rendered epicardial ablation unattractive to both patients and 
their referring physicians, unless cardiac surgery is indicated 
for other reasons.
Emerging techniques: review  
of clinical results
The 2006 American College of Cardiology/American Heart 
Association/European Society for Cardiology guidelines for 
the management of patients with AF have cited minimally 
invasive surgical techniques for atrial fibrillation ablation 
as a work-in-progress at the research level.20 However, the 
minimally invasive approach, with its lesser ensuing morbid-
ity and increased tolerability for patients, was underscored 
to have the potential to reform the algorithms for treatment 
of AF, provided that it is as reliable as the gold standard 
techniques.
Choice of the lesion set: implications  
for minimally invasive approaches
Both a biatrial lesion set and an ablation procedure con-
fined to the left atrium can be performed via the minimally 
invasive approach. However, a reliable yet fast and safe 
procedure for AF ablation is even more important in this 
context. Minimally invasive surgery is associated with a 
higher level of technical complexity, prolonged operative 
times,21 and on occasion, a more difficult exposure. Extra 
cardiopulmonary bypass time is required to perform a 
  biatrial lesion pattern, with additional right atriotomy when 
surgery to the mitral valve alone is scheduled. Although a 
biatrial classic maze is technically achievable by a mini-
mally invasive route,8 the industry has produced several 
disposable devices designed for minimally invasive epi-
cardial ablation. All these devices are based on a left atrial, 
beating heart ablation concept. Such characteristics can be 
particularly advantageous in the minimally invasive setting. 
It has been ascertained that the pathophysiologic substrate 
of AF can vary from simpler forms (arrhythmogenic foci 
around the pulmonary veins) to more complex electrophysi-
ologic patterns involving both the atria.22,23 Unfortunately 
almost all mapping data available in the literature have 
been obtained from nonsurgical patients with lone AF, 
and in such patient populations the AF displays a biatrial 
substrate in the majority of cases.24 Furthermore, patients 
coming for surgery to the atrioventricular valve(s) may 
represent a distinct subgroup displaying predominantly the 
same pathophysiologic mechanism for AF.
The established Cox maze procedure entails a complex 
set of atrial lesions involving both the atria (Figure 3). 
Ablation procedures confined to the left atrium consist 
of isolation of the pulmonary veins either using the “en 
bloc” technique (a single ablation line encircling the four 
vein orifices altogether) or by isolating separately the right 
and left pulmonary veins cuffs. A “mitral line” usually 
completes this procedure by connecting the pulmonary 
vein line to the mitral annulus, and can be performed either 
endocardially or epicardially. The biatrial procedures may 
add to this set a cavocaval ablation line, and other lesions 
directed through the coronary sinus, tricuspid orifice, and 
interatrial septum on the right atrial side. Amputation or 
isolation of the right/left atrial appendages may complete 
the procedure. A number of modifications have been pro-
posed to this lesion set,25 while different energy sources 
have almost entirely replaced the original “cut-and-sew” 
technique (radiofrequency, cryoablation, ultrasound, and 
microwave energy). These are less technically demanding 
and their results, in terms of postoperative sinus rhythm 
conversion, have been reported in a systematic review to 
be not significantly different from those claimed after the 
“cut-and-sew” approach.26 A clear relationship between the 
maintenance of postoperative sinus rhythm and the type of 
lesion pattern (biatrial versus left atrial) could not be estab-
lished in the same meta-regression analysis. On the contrary, 
lesion transmurality appears to be an important determinant 
of therapeutic success. While ablation within the left atrium Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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Figure 3 A) Left atrial lesions. Red interrupted line: Circular “box lesion” around the pulmonary vein orifices (or isolation of the left and right pulmonary cuffs independently) 
plus a lesion towards the mitral annulus (“mitral line”). Yellow interrupted line: Supplementary left atrial lesions, isolation of the left atrial appendage plus connecting line.   
B) Right atrial lesions. Cavocaval line, cavotricuspid line, isolation of the right atrial appendage plus connecting line towards the tricuspid annulus (the latter line is on the 
lateral right atrial wall).
Abbreviations: RSPV, right superior pulmonary vein; RiPV, right inferior pulmonary vein; LSPV, left superior pulmonary vein; LiPV, left inferior pulmonary vein; RAA, right 
atrial appendage; LAA, left atrial appendage; SVC, superior vena cava;  iVC, inferior vena cava.
is essential for any surgical treatment of AF, the creation of 
supplementary right-sided lesions may increase the risk of 
pacemaker requirement.20,27
The evidence collected so far for the reliability of bia-
trial surgical ablation procedures versus those confined to 
the left atrium is conflicting. In a meta-analysis, the biatrial 
procedures appeared to confer superior results in terms of 
maintenance of sinus rhythm over time.28 However, this 
meta-analysis included studies published in the 1995–2005 
period, and is limited by the inclusion of several retrospective 
trials. Evidence has been collected showing that isolation of 
the pulmonary veins coupled with creation of a “mitral line” 
is actually enough to interrupt the macro-reentrant circuit 
in cases of AF associated with mitral valvular disease.29 
Meanwhile, the lesions within the right atrium, septum, and 
base of the left atrial appendage may not confer a significant 
benefit in terms of major clinical outcomes (maintenance 
of sinus rhythm and thromboembolic events).30 Controlled 
randomized trials addressing these issues have been recently 
published. The largest of these studies randomized 299 
patients scheduled for cardiac surgery via median sternotomy 
to receive radiofrequency AF ablation with either a left 
atrial technique (pulmonary vein isolation plus connecting 
lines to the mitral annulus and atrial roof) or a biatrial tech-
nique (adding cavocaval, cavotricuspid isthmus, and lateral 
free wall lesions to the previous set).19 The percentage of 
patients in sinus rhythm at the end of a mean 28-month 
follow-up was comparable among the study groups. A mark-
edly increased left atrial diameter (.80 mm) was the sole 
significant   predictor of late AF recurrence. In another ran-
domized investigation, the early and late results of pulmonary 
vein isolation plus creation of a “mitral line” were similar to 
that after the Cox maze III procedure in the context of mitral 
surgery.31 The clinical outcomes were superior in both groups 
versus the control patients, who received no ablation at all. 
Two other controlled trials yielded similar conclusions.7,32 
The comparability of outcomes for left atrial and biatrial pro-
cedures apparently is not offset by the type of left atrial lesion 
set, namely whether the isolation of the left atrial appendage 
and creation of a “mitral line” are added to pulmonary vein 
isolation.33 The latter randomized study was conducted in a 
homogeneous group of patients undergoing surgery to the 
atrioventricular valve(s) and cryoablation. The fairly low 
observed rates of freedom from recurrent AF (57%–67%) 
have been attributed to the practice of not administering 
antiarrhythmic drugs in the perioperative period during this 
study. This observation indirectly confirms the usefulness 
of pharmacologic therapy to optimize the results of surgical 
ablation. Although no relevant trials have been conducted 
to date, there is no suggestion in the literature of different 
outcomes depending on the type of pulmonary vein isolation 
(en bloc versus separate left and right cuff ablation). Finally, Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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it is noticeable that the rate of freedom from recurrent AF 
at follow-up after intraoperative radiofrequency ablation for 
permanent AF has progressively improved over time. In the 
early 2000s a freedom rate approaching 70% was considered 
to be an adequate result,9,34 while freedom rates are now 
approximately 90%.5,10,9
Thus, the conclusions of the meta-analysis by Barnett et al 
should be critically revised on the basis of this evidence, and 
probably reperformed including randomized controlled trials 
alone. A summary of the recent evidence from randomized 
studies is reported in Table 1. These data are a theoretical 
basis for the development of disposable instruments providing 
epicardial, offpump AF ablation by circular lesion around 
the pulmonary vein orifices. The radiofrequency or high-
intensity focused ultrasound technologies are invariably used 
for these purposes. Tip-cooling and vacuum-assistance are 
used in some cases, in order to facilitate the adherence of the 
ablation probe to the beating cardiac tissue and the creation 
of a transmural lesion. Initial reports exist for the results 
of these devices in the context of median sternotomy. The 
Epicor Cardiac Ablation System (St Jude Medical, St Paul, 
MN) enables offpump creation of a circular box lesion around 
the pulmonary veins and the mitral line using two different 
devices, with high-intensity ultrasound energy. After setting 
up the system, the surgeon can proceed with preparation 
for cardiopulmonary bypass as required, thus saving both 
operative and pump time. This device can be potentially used 
via a minimally invasive route, and in the only published expe-
rience, a 77% rate of freedom from recurrent arrhythmia at 
follow-up was reported.35 However, few patients (n =14) were 
included in this research and larger data sets are required. 
Initial clinical data are available also for devices designed 
specifically for use in minimally invasive settings, eg, the 
Cobra Adhere XL System (Estech Inc., San Ramon, CA) 
which uses radiofrequency energy, and the Flex 10 Ablation 
System (Guidant Inc., Indianapolis, IN) which uses micro-
wave energy.36,37 Both devices rely on the creation of a box 
lesion around the pulmonary veins;   however, the reported 
rates of freedom from AF at follow-up were markedly dif-
ferent for these devices (92% versus 42%, respectively). This 
discrepancy may be partially accounted for by population 
bias because the patients enrolled in the first study received 
minimally invasive surgery for mitral disease and concomitant 
AF ablation, whereas the patients in the second study had 
lone AF. This should prompt caution when considering the 
extension of the indication for surgical epicardial ablation to 
individuals with lone AF. However, the authors did comment 
that their disappointing results could be ascribed to ineffective 
creation of complete lesions, given that the microwave probe 
was not vacuum-assisted.37
Advantages versus conventional surgical 
approach
Full sternal splitting leads to alterations of the respiratory 
mechanics, thus impacting the postoperative pulmonary 
recovery, particularly in patients with chronic lung disease. 
Median sternotomy is a moderately painful incision and 
is prone to complications, which may range from serous 
discharge to sternal instability and life-threatening medias-
tinitis. Surgery to the mitral valve via a minimally invasive 
approach is a reproducible operation, either via minithora-
cotomy, peripheral cannulation, endoaortic clamping, and 
total videoscopic assistance (Port-Access system)38,39 or via 
minithoracotomy, peripheral cannulation, direct vision, and 
external aortic clamping.40 A recent propensity-matched 
investigation in a total of 715 patients showed that the 
minimally invasive strategy for cardiac surgery is associ-
ated with a shorter mechanical ventilation time, decreased 
postoperative pain, and improved patient satisfaction, 
although at the price of longer cardiopulmonary bypass and 
aortic clamping times.21 Concomitant AF ablation is feasible 
during minimally invasive surgery to the atrioventricular 
valve(s), with a reported 28% rate of arrhythmia recurrence 
at follow-up after port-access mitral repair/replacement plus 
radiofrequency isolation of the pulmonary veins.41 A unipolar 
radiofrequency instrument was used endocardially during 
cardiopulmonary bypass in that series. In a randomized 
study setting, a 93.6% freedom from late AF was reported 
in patients receiving onpump endocardial radiofrequency 
ablation during minimally invasive valvular surgery.8 In 
the majority of the cases included in that study a left atrial 
Table 1 Summary of randomized controlled trials comparing the 
results of biatrial versus left atrial ablation procedures published 
in the 2005–2009 period*
Study Sample  
size (n)
Left atrial: SR 
at follow-up
Biatrial: SR 
at follow-up
P*
wang et al19 299 85% 84% 0.87
Albrecht et al31 60 90%§ 85% 0.21
Srivastava et al33 160 67.5% and 57.5%† 62.5% NS
*Probability  value  for  intergroup  comparison  of  primary  outcome  variable 
(maintenance of SR). †in this study patients were randomized to four study groups, 
ie, biatrial ablation versus pulmonary vein isolation alone (67.5% freedom from AF at 
follow-up) versus pulmonary vein isolation plus other left atrial ablation lines (57.5% 
freedom from AF at follow-up) versus control (no ablation). §in this study patients 
were randomized to three study groups, ie, pulmonary vein isolation and ablation 
(90% freedom from AF at follow-up) versus biatrial maze (85% freedom from AF at 
follow-up) versus controls (no ablation).
Abbreviations: SR, sinus rhythm; NS, not significant; AF, atrial fibrillation.Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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ablation procedure was performed, and the lesions were 
extended to the right side only in those cases requiring a 
procedure on the tricuspid valve or the interatrial septum. 
Unfortunately the authors did not report differential results 
of patients   receiving the biatrial versus the left atrial proce-
dure.   However, this is   predominantly a left-sided ablation 
series and the outstanding clinical results reported should 
be essentially considered as the expression of this strategy. 
The left atrial lesion sets included isolation of the pulmonary 
vein cuffs and left atrial appendage and creation of a “mitral 
line”. In a direct comparison of cryomaze either through con-
ventional sternotomy or with a minimally invasive system, 
comparable rates of follow-up arrhythmia recurrence (2.2% 
versus 2.4%) and comparable rates of major perioperative 
morbidity were observed. The rate of postoperative perma-
nent pacemaker requirement was reduced, possibly due to 
enhanced videoscopic exposure of the tissue targets.25 The 
possibility of a considerable incidence of hemidiaphragm 
paralysis was also noticed, as a consequence of phrenic 
nerve trauma while entering the pericardium from the right 
pleural cavity.
In general terms, the minimally invasive ablation strate-
gies have proved to be noninferior in their main clinical 
results to ablation via full sternotomy. A left atrial lesion set, 
coupled with adequate perioperative pharmacologic therapy, 
appears to be feasible via right minithoracotomy. The known 
advantages of minimally invasive valvular surgery (patient 
satisfaction, shorter ventilation, and perhaps reduced mor-
bidity) are not offset by concomitant ablation. Additionally, 
AF ablation can be performed during minimally invasive 
procedures other than surgery on the atrioventricular valve(s), 
thus expanding its potential field of application.
Future implications: surgical 
ablation of lone AF
Unfortunately the currently available data are insufficient 
to perform a formal meta-analysis of the clinical results 
of radiofrequency AF ablation via the minimally invasive 
route versus conventional median sternotomy. Postoperative 
length of stay, morbidity, and rate of maintenance of sinus 
rhythm should be included among the endpoints of such a 
meta-analysis.
Although still inferential, it can be reasonably expected 
that patients undergoing epicardial ablation through a mini-
mally invasive access would have benefits similar to those 
observed after minimally invasive mitral valve surgery versus 
surgery via the conventional approach. However, the pres-
ence of mitral valvular disease in these patients represents 
a major confounder. Comparing the gross rates of freedom 
from AF after surgical ablation versus after state-of-the-art 
transcatheter procedures could be inherently misleading, 
because different pathophysiologic mechanisms may subtend 
the arrhythmia in these circumstances. Trigger focuses within 
the pulmonary vein cuffs have been linked with paroxysmal 
AF, thus substantiating the excellent results of radiofrequency 
isolation of the pulmonary veins alone.42 In the setting of 
permanent AF, more advanced remodeling of the atrial 
wall may determine ubiquitous trigger foci. Nonetheless, 
  macro-reentrant circuits around the pulmonary cuffs, particu-
larly if atrial dilatation coexists, are believed to sustain the 
arrhythmia in this case. Pulmonary vein isolation and creation 
of a “mitral line” should then interrupt such a circuit.43 These 
issues can be properly addressed only by a direct comparison 
of nonvalvular AF ablation via the transcatheter versus the 
surgical technique, and by a deeper comprehension of the 
mechanisms triggering AF in different patient subgroups. For 
research purposes, pre- or intraoperative electrophysiologic 
study may be performed.
From the feasibility point of view, offpump, epicardial, 
minimally invasive ablation has a limited traumatic profile, 
reproducibility, and expected optimal clinical results. Car-
diopulmonary bypass and ensuing multisystem morbidity, 
systemic inflammatory reaction, and prolonged hospitaliza-
tion are avoided. These elements may prompt a more liberal 
policy to indicate minimally invasive epicardial ablation in 
patients with drug-refractory, lone AF. The performance of 
a randomized investigation versus transcatheter ablation is 
encouraged. Centers experienced in minimally invasive sur-
gery to the atrioventricular valves may be the ideal candidates 
to lead this research. Early results for epicardial ablation of 
lone AF with high-intensity focused ultrasound technology 
via sternotomy have been encouraging.35 Further studies 
using minimally invasive equipments are ongoing.
Our sample size calculation analysis revealed that in a 
prospective study of transcatheter versus epicardial ablation 
of lone AF, each study group should include 125 subjects 
to have sufficient statistical power to detect a significant 
difference between groups in terms of rate of recurrent AF 
at hospital discharge and rate of recurrent AF at six-month 
follow-up.
Conclusion
Overall, the evidence indicates that a reliable AF ablation 
can be safely performed with a lesion set confined to the 
left atrium. To this end, disposable devices for epicardial 
offpump ablation in the minimally invasive setting have Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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become available in recent years. With ongoing technological 
refinements it is reasonable to expect gold standard clinical 
results in terms of arrhythmia termination. Radiofrequency 
technology appears to be the most promising in this scenario. 
However, we can expect that the best results possible from 
minimally invasive ablation technologies can be achieved 
when the surgical indication is correctly posed. Hence, ongo-
ing research is required.
As additional clinical data become available, these 
may suffice to support a revision of the published 
guidelines, given that the less traumatic profile of the 
minimally invasive techniques may allow for an exten-
sion of the surgical indications to patients with lone AF. 
There is a need for a randomized, controlled, multicenter 
trial comparing state-of-the-art transcatheter ablation 
versus minimally invasive epicardial, offpump ablation 
to treat lone AF. This would be the most reliable tool to 
ascertain on a clinical and cost-efficacy basis the rela-
tive place of these techniques in the management of this 
pandemic disease.
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